3d
Pharmaceutical Technology on MSNEC approves MSD’s pneumococcal 21-valent conjugate CapvaxiveThe decision was influenced by the positive recommendation from the EMA’s Committee for Medicinal Products for Human Use.
Sponsored by Pfizer - For actress and producer Elizabeth Banks, turning 50 meant prioritizing preventative care to stay ...
Merck (MRK), known as MSD outside of the United States and Canada, announced that the European Commission, or EC, has approved CAPVAXIVE, or ...
The vaccine protects against the serotypes responsible for the majority of adult invasive pneumococcal disease ...
Merck MRK announced that the European Commission (“EC”) has approved its 21-valent pneumococcal conjugate vaccine (“PCV”), Capvaxive, for the prevention of invasive pneumococcal disease ...
In an attempt to strike a pitch-perfect tone with Generation X, Pfizer has recruited Elizabeth Banks as the face of a new ...
Two words come to mind for Elizabeth Banks after her showdown with shingles: "Not fun." ...
Antibiotic-resistant bacteria are a serious public health threat. Understanding the biology of these bacteria—such as how ...
These findings demonstrate that the capsular serotype and genetic background significantly impact pneumococcal growth kinetics. The resultant growth features likely depend on the interaction between ...
MSD has received approval from the European Commission (EC) for Capvaxive, a pneumococcal 21-valent conjugate vaccine, to prevent invasive disease and pneumonia due to Streptococcus pneumoniae ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results